Jacopo Sgrignani
Jacopo Sgrignani
Scientist, IRB, Bellinzona
Email verificata su
Citata da
Citata da
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
J Chen, I Guccini, D Di Mitri, D Brina, A Revandkar, M Sarti, E Pasquini, ...
Nature genetics 50 (2), 219-228, 2018
Structural biology of STAT3 and its implications for anticancer therapies development
J Sgrignani, M Garofalo, M Matkovic, J Merulla, CV Catapano, A Cavalli
International journal of molecular sciences 19 (6), 1591, 2018
Functionalized Fe‐filled multiwalled carbon nanotubes as multifunctional scaffolds for magnetization of cancer cells
R Marega, F De Leo, F Pineux, J Sgrignani, A Magistrato, AD Naik, ...
Advanced Functional Materials 23 (25), 3173-3184, 2013
Influence of the membrane lipophilic environment on the structure and on the substrate access/egress routes of the human aromatase enzyme. A computational study
J Sgrignani, A Magistrato
Journal of chemical information and modeling 52 (6), 1595-1606, 2012
Structural investigation of the 7-chloro-3-hydroxy-1 H-quinazoline-2, 4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. synthesis, pharmacological …
V Colotta, D Catarzi, F Varano, O Lenzi, G Filacchioni, C Costagli, A Galli, ...
Journal of medicinal chemistry 49 (20), 6015-6026, 2006
Tuning the activity of Zn (II) complexes in DNA cleavage: clues for design of new efficient metallo-hydrolases
C Bazzicalupi, A Bencini, C Bonaccini, C Giorgi, P Gratteri, S Moro, ...
Inorganic chemistry 47 (12), 5473-5484, 2008
The Structural Role of Mg2+ Ions in a Class I RNA Polymerase Ribozyme: A Molecular Simulation Study
J Sgrignani, A Magistrato
The Journal of Physical Chemistry B 116 (7), 2259-2268, 2012
QM/MM MD simulations on the enzymatic pathway of the human flap endonuclease (hFEN1) elucidating common cleavage pathways to RNase H enzymes
J Sgrignani, A Magistrato
Acs Catalysis 5 (6), 3864-3875, 2015
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course
J Muri, V Cecchinato, A Cavalli, AA Shanbhag, M Matkovic, M Biggiogero, ...
Nature immunology 24 (4), 604-611, 2023
Computational approaches elucidate the allosteric mechanism of human aromatase inhibition: a novel possible route to Small-molecule regulation of CYP450s activities?
J Sgrignani, M Bon, G Colombo, A Magistrato
Journal of chemical information and modeling 54 (10), 2856-2868, 2014
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
F Bianchini, V Crivelli, ME Abernathy, C Guerra, M Palus, J Muri, ...
Science immunology 8 (81), eade0958, 2023
Single or Multiple Access Channels to the CYP450s Active Site? an Answer from Free Energy Simulations of the Human Aromatase Enzyme
AC Alessandra Magistrato, Jacopo Sgrignani, Rolf Krause
J. Phys. Chem. Letter, 2017
Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer
A Spinello, S Martini, F Berti, M Pennati, M Pavlin, J Sgrignani, G Grazioso, ...
European journal of medicinal chemistry 168, 253-262, 2019
The inactivation of TEM-1 by Avibactam (NXL-104): insights from QM/MM metadynamics simulations.
CG Sgrignani J, Grazioso G, De Amici M
Biochemistry, 2014
Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease
MB Wright, J Varona Santos, C Kemmer, C Maugeais, JP Carralot, ...
Nature communications 12 (1), 4662, 2021
Structural and Dynamic Properties of Monoclonal Antibodies Immobilized on CNTs: A Computational Study
AM Federica De Leo, Jacopo Sgrignani, Davide Bonifazi
Chemistry an European Journal, 2013
Computationally driven structure optimization, synthesis, and biological evaluation of imidazole-based proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors
C Lammi, J Sgrignani, A Arnoldi, G Lesma, C Spatti, A Silvani, G Grazioso
Journal of medicinal chemistry 62 (13), 6163-6174, 2019
Machine learning analyses of antibody somatic mutations predict immunoglobulin light chain toxicity
M Garofalo, L Piccoli, M Romeo, MM Barzago, S Ravasio, M Foglierini, ...
Nature Communications 12 (1), 3532, 2021
First-principles modeling of biological systems and structure-based drug-design
J Sgrignani, A Magistrato
Current computer-aided drug design 9 (1), 15-34, 2013
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
M Zoma, L Curti, D Shinde, D Albino, A Mitra, J Sgrignani, SN Mapelli, ...
Nature Communications 12 (1), 4147, 2021
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20